human | 遺伝子名 | chronic granulomatous disease |
同義語(エイリアス) | 67 kDa neutrophil oxidase factor; Neutrophil NADPH oxidase factor 2; NOXA2; p67phox; p67-phox; Neutrophil cytosol factor 2; NCF2; NCF-2; P67-PHOX | |
SWISS-PROTのID | SWISS-PROT:P19878 | |
EntrezGeneのID | EntrezGene:4688 | |
その他のDBのID | HGNC:7661 |
human | 遺伝子名 | chronic granulomatous disease |
同義語(エイリアス) | Neutrophil NADPH oxidase factor 1; 47 kDa neutrophil oxidase factor; Neutrophil cytosol factor 1; NCF-47K; NCF-1; NCF1; NOXO2; p47-phox; p47phox; NCF1A; SH3PXD1A | |
SWISS-PROTのID | SWISS-PROT:P14598 | |
EntrezGeneのID | EntrezGene:653361 | |
その他のDBのID | HGNC:7660 |
本文中に表示されているデータベースの説明
出典:Wikipedia
出典:『Wikipedia』 (2011/07/13 02:22 UTC 版)
Chronic granulomatous disease (CGD) (also known as Bridges–Good syndrome, Chronic granulomatous disorder, and Quie syndrome) is a diverse group of hereditary diseases in which certain cells of the immune system have difficulty forming the reactive oxygen compounds (most importantly, the superoxide radical) used to kill certain ingested pathogens. This leads to the formation of granulomata in many organs. CGD affects about 1 in 200,000 people in the United States, with about 20 new cases diagnosed each year.